Bepreve

Active Ingredient(s): Bepotastine Besilate
FDA Approved: * September 8, 2009
Pharm Company: * ISTA PHARMS
Category: Allergies, Cough & Cold

Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine.[1] It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively. It is currently marketed in the United States as an eye drop under the brand-name Bepreve, by ISTA Pharmaceuticals, a subsidiary of Bausch + Lomb. Contents 1 Pharmacology 2 Marketing history 3 Sales and patents 4 Clinical trials 5 References Pharmacology Bepotastine ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Bepreve 15 mg/ml Ophthalmic Solution/ Drops

NDC: 24208-629

Labeler:

Bausch & Lomb Incorporated

Bepreve 15 mg/ml Ophthalmic Solution/ Drops

NDC: 54868-6299

Labeler:

Physicians Total Care, Inc.

Bepreve 15 mg/ml Ophthalmic Solution/ Drops

NDC: 67425-007

Labeler:

Ista Pharmaceuticals, Inc